Search the Newsreel

Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Recommendation of "Hold" from Analysts

Analysts have issued a "Hold" consensus recommendation for Fulgent Genetics (NASDAQ:FLGT), with an average 12-month price target of $27.00. The company recently reported Q2 2026 revenue of $85.4 million, missing estimates, and a non-GAAP loss of $0.58 per share, which exceeded expectations. Management also …

HBFL5059230 Bond Profile — Key Metrics

This article provides key metrics for the H.B. Fuller Company (HBFL5059230) bond, detailing its coupon rate, issue and maturity dates, outstanding amount, and face value. It also includes a description of H.B. Fuller Co.'s business segments, which include Hygiene, Health, and Consumable Adhesives, Engineering …

Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results

Fulgent Genetics (NASDAQ:FLGT) reported disappointing quarterly earnings, missing analyst estimates for both EPS and revenue due to revenue-cycle issues, including delayed billing and lower collection rates. The company also reduced its full-year 2026 guidance, forecasting lower revenue and negative non-GAAP EPS. Despite these setbacks, …

Fulgent Genetics Q2 2026 Earnings Call Transcript

Key Points Interested in Fulgent Genetics, Inc.? Here are five stocks we like better. Second-quarter revenue rose to $85.4 million, up 20% sequentially, with Bako Diagnostics and StrataDx contributing $16.9 million. However, billing-system transition issues reduced collections, pressured gross margins and contributed to a …

Fulgent Genetics (FLGT) Stock Price Slides As Losses Deepen Guidance Falls

Fulgent Genetics (FLGT) saw its stock price fall by approximately 18% after reporting a significant quarterly net loss of US$29.5 million and lowering its full-year guidance. The company's revenue increased slightly year-on-year, but profitability challenges persist, with widening losses and reduced non-GAAP gross margins. …

Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary

Fulgent Genetics Inc (FLGT) has released its earnings summary for the quarter ended June 30. The report, provided by Refinitiv, gives an overview of the company's financial performance. Full access to the article is available through a TradingView subscription.

Fulcrum Therapeutics (NASDAQ:FULC) Posts Earnings Results, Misses Expectations By $0.13 EPS

Full House Resorts Announces Second Quarter Earnings Release Date

Full House Resorts (NASDAQ: FLL) announced that it will release its second quarter 2026 financial results on Thursday, August 6, 2026. This will be followed by a conference call at 4:30 p.m. ET, and investors can access the live audio webcast or a replay …

Fulgent Genetics cuts FY26 revenue guidance amid billing delays

Fulgent Genetics reported Q2 2026 revenue of $85.4 million and a non-GAAP loss of $16.2 million, missing analyst estimates. The company lowered its full-year 2026 revenue guidance to $330-$340 million and non-GAAP loss to $63-$67 million, attributing the revisions to delays in its billing …

Fulu Holdings Limited Revenue Breakdown – HKEX:2101

Fulgent Genetics Q2 Earnings Call Highlights

Fulgent Genetics reported second-quarter 2026 revenue of $85.4 million, a 20% sequential increase, but faced challenges from billing system transition issues that pressured collections and gross margins, leading to a $29.5 million GAAP net loss. The company lowered its 2026 revenue guidance to $330 …

Fulcrum Therapeutics Market Sentiment

This article analyzes the market sentiment for Fulcrum Therapeutics (FULC) based on several key signals: analyst consensus, short interest, options flow, and insider activity. The overall analyst consensus is "Hold" with a target price of $8.00, while short interest is rising, and insider activity …

Fulgent Genetics (NASDAQ:FLGT) Updates FY 2026 Earnings Guidance

Fulgent Genetics (NASDAQ:FLGT) has updated its FY 2026 earnings guidance, projecting an EPS of -$2.35 to -$2.22 and revenue of $330 million to $340 million, which falls below consensus estimates. The company also missed Q2 earnings expectations, reporting an adjusted EPS of -$0.58 and …

Full House Resorts' Q2 call replay will remain online through Aug. 20

Full House Resorts (NASDAQ: FLL) announced its second quarter 2026 financial results will be released on Thursday, August 6, 2026, followed by a conference call at 4:30 p.m. ET. Investors can access the live audio webcast and a replay through the company’s investor relations …

Full House Resorts (FLL) Projected to Announce Earnings on Thursday

Full House Resorts (FLL) is expected to report its Q2 2026 earnings before market open on Thursday, August 6th. Analysts project a loss of $0.1743 per share and revenue of about $78.4 million. The company's prior quarter results showed a $0.23 per-share loss, beating …

Fulgent Genetics earnings missed by $0.14, revenue fell short of estimates

Fulgent Genetics (FLGT) Earnings Date and Reports 2026 $FLGT

Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Misses Revenue Estimates

Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss

The Bull Case For Fulton Financial (FULT) Could Change Following Q2 2026 Results And Completed Buybacks

Fulcrum Therapeutics (NASDAQ: FULC) ends pociredir, explores alternatives

Fulgent Genetics Inc (FLGT) Financial Health: Profitability & Balance Sheet Analysis

Fulgent Genetics Inc (FLGT) currently holds a financial score of 6.89, placing it 52nd out of 75 in the Healthcare Providers & Services industry, indicating stable financial health and high operating efficiency. Despite this, its latest quarterly revenue decreased by 3.16% year-over-year to $71.14M, …

Behavioral Patterns of FLGT and Institutional Flows

This article analyzes behavioral patterns and institutional flows for Fulgent Genetics Inc. (NASDAQ: FLGT), suggesting a near-term neutral sentiment that may pause mid- and long-term weakness. It highlights an exceptional 96.0:1 risk-reward setup targeting a 26.9% gain with minimal risk. The report also provides …

Full House Resorts Inc (FLL) Financial Health: Profitability & Balance Sheet Analysis

The financial health of Full House Resorts Inc (FLL) is currently weak, with a TradingKey financial score of 6.40, ranking 95 out of 119 in its industry. The company's recent quarterly revenue saw a slight year-over-year decrease of 0.85% to $74.42 million, while its …

H.B. Fuller To Go Ex-Dividend On July 30th, 2026 With 0.245 USD Dividend Per Share

H.B. Fuller (NYSE: FUL) is set to go ex-dividend on July 30th, 2026, with a dividend payout of 0.245 USD per share. This upcoming ex-dividend date is a key event for investors looking to receive the dividend.

Skillful Craftsman Education Technology Ltd (EDTK) Financial Health: Profitability & Balance Sheet Analysis

This article focuses on the financial health of Skillful Craftsman Education Technology Ltd (EDTK), specifically analyzing its profitability and balance sheet. It presents real-time stock data, showing a slight increase in price, and highlights the company's market capitalization. The detailed financial analysis aims to …

HB Fuller Number of Employees 2026 | Employee Count & Headcount Data

H.B. Fuller Co. (FUL) had approximately 7,143 total employees worldwide as of March 2026, marking a 1.2% decline from 2023. Despite this, the company is actively hiring, with 368 active job postings in 2026, a 49.5% increase from the previous year. The workforce is …

5 Must-Read Analyst Questions From Fulton Financial’s Q2 Earnings Call

FULT|Fulton Financial Corp|Price:24.680|Chg%:+0.280

TradingKey provides a comprehensive stock analysis of Fulton Financial Corp (FULT), highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Banking Services industry. The company has strong revenue and profit growth, pays a stable high dividend, and analysts have a …

H.B. Fuller Company (FUL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of H.B. Fuller Company (FUL), including its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. While the stock's price is currently suitable for range-bound swing trading, the overall signal …

Fuller, Smith & Turner (LON:FSTA) Insider Purchases 1,370 Shares

Insider Selling: Fuller, Smith & Turner (LON:FSTA) Insider Sells £44,989.90 in Stock

Fulcrum Therapeutics Inc (FULC) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Fulcrum Therapeutics Inc (FULC), noting its current financial score of 7.26, which ranks 138 out of 385 in the Biotechnology & Medical Research industry, indicating a weak financial status but high operating efficiency. The report highlights that …

H.B. Fuller Company Revenue Breakdown – DUS:HB1

H.B. Fuller Company (DUS:HB1) reported a total revenue of €3.00 billion last year. The Hygiene, Health and Consumable Adhesives segment was the top performer, contributing €1.34 billion, while the United States was the largest regional contributor with €1.31 billion in revenue. The article provides …

Fulgent Genetics Inc (FLGT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Fulgent Genetics Inc (FLGT), noting its score of 6.80, which ranks 25 out of 75 in the Healthcare Providers & Services industry. The company's beta of 0.93 indicates it tends to underperform in up markets but decline …

Full Truck Alliance Co Ltd (YMM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Full Truck Alliance Co Ltd (YMM), outlining its current price momentum, support and resistance levels, and indicator and moving average signals. The stock is currently trading between a resistance level of 9.82 and a support level of …